Becton Dickinson & Co EV/Sales
Was ist das EV/Sales von Becton Dickinson & Co?
EV/Sales von Becton Dickinson & Co. ist 4.13
Was ist die Definition von EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales von Unternehmen in Health Care Sektor auf NYSE im Vergleich zu Becton Dickinson & Co
Was macht Becton Dickinson & Co?
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Unternehmen mit ev/sales ähnlich Becton Dickinson & Co
- Standard Life Private Equity Trust Plc hat EV/Sales von 4.13
- AM Resources hat EV/Sales von 4.13
- EQT hat EV/Sales von 4.13
- Byleasing hat EV/Sales von 4.13
- Chesapeake Granite Wash Trust hat EV/Sales von 4.13
- Canadian Overseas Petroleum hat EV/Sales von 4.13
- Becton Dickinson & Co hat EV/Sales von 4.13
- Bathurst Resources hat EV/Sales von 4.13
- JD Health International hat EV/Sales von 4.13
- SAP SE hat EV/Sales von 4.13
- Indiabulls Real Estate hat EV/Sales von 4.13
- Jupiter Emerging & Frontier Income Trust PLC hat EV/Sales von 4.13
- Chimera Investment Corp hat EV/Sales von 4.14